Total Soluble and Endogenous Secretory Receptor for Advanced Glycation Endproducts as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial.

HM Colhoun, DJ Betteridge, P Durrington, G Hitman, A Neil, S Livingstone, V Charlton-Menys, W Bao, DA Demicco, GM Preston, H Deshmukh, K Tan, JH. Fuller

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    JournalDiabetes
    Publication statusPublished - 2011

    Cite this